论文部分内容阅读
目的:探讨妈咪爱、思密达联合应用治疗新生儿高胆红素血症的临床疗效。方法:将120例新生儿黄疸患儿随机分为对照组和治疗组各60例,对照组予以常规治疗,治疗组在常规治疗的基础上口服妈咪爱和思密达,比较两组疗效。结果:治疗组在日均胆红素下降值、总胆红素降至<80μmol/L天数和总有效率方面与对照组比较,差异均有统计学意义(P<0.01)。结论:妈咪爱与思密达联合应用可加速胆红素分解排出、阻止重吸收,用于治疗新生儿高胆红素血症疗效肯定,值得临床推广。
Objective: To explore the clinical effect of mommy love, smecta combined treatment of neonatal hyperbilirubinemia. Methods: A total of 120 neonates with jaundice were randomly divided into control group and treatment group, 60 cases in each group. The control group was given conventional treatment. The treatment group was given oral mommy and Smectite on the basis of routine treatment. The curative effect was compared between the two groups. Results: Compared with the control group, the treatment group had significant difference (P <0.01) in daily bilirubin level, total bilirubin level <80μmol / L and total effective rate. Conclusion: Mommy love and smecta combined application can accelerate the decomposition of bilirubin, prevent reabsorption, for the treatment of neonatal hyperbilirubinemia positive effect, is worthy of clinical promotion.